EP Patent

EP4438606A1 — New crystal form of nucleoside compound and salt thereof

Assigned to Shenzhen Antiv Pharma Co Ltd · Expires 2024-10-02 · 2y expired

What this patent protects

The present invention provides novel crystalline forms of a nucleoside compound and salts thereof, which belongs to the technical field of medicines. The nucleoside compound is compound ATV014. The present invention focuses on investigating whether compound ATV014 has multiple so…

USPTO Abstract

The present invention provides novel crystalline forms of a nucleoside compound and salts thereof, which belongs to the technical field of medicines. The nucleoside compound is compound ATV014. The present invention focuses on investigating whether compound ATV014 has multiple solid forms. Surprisingly, it is discovered that compound ATV014 exists in a variety of stable solid forms, comprising: ATV-014 free base crystalline form I, ATV-014 hydrochloride crystalline form I, ATV-014 hydrochloride crystalline form II, ATV-014 hydrochloride crystalline form III, ATV-014 hydrochloride crystalline form IV, ATV-014 hydrobromide crystalline form I, and ATV-014 p -toluenesulfonate crystalline form I. The provided novel crystalline forms of the compound ATV014 free base and salts thereof have good solubility and thermal stability, and better bioavailability and dissolution curve in a specific preparation; and which are suitable for use in a specific pharmaceutical preparation due to the good permeability and thermal stability thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP4438606A1
Jurisdiction
EP
Classification
Expires
2024-10-02
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Antiv Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.